Erratum: Clinical ascertainment of health outcomes among adults treated for childhood cancer (JAMA - Journal of the American Medical Association (2013) 309, 22 (2371-2381) DOI:10.1001/jama.2013.6296);Clinical ascertainment of health outcomes among adults treated for childhood cancer

JAMA

Volumn 309, Issue 22, 2013, Pages 2371-2381

  Hudson, Melissa M ^a   Ness, Kirsten K ^a   Gurney, James G ^a   Mulrooney, Daniel A ^a   Chemaitilly, Wassim ^a   Krull, Kevin R ^a   Green, Daniel M ^a   Armstrong, Gregory T ^a   Nottage, Kerri A ^a   Jones, Kendra E ^a   Sklar, Charles A ^b   Srivastava, Deo Kumar ^a   Robison, Leslie L ^a  

^a UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ANTHRACYCLINE; ANTINEOPLASTIC ANTIMETABOLITE; BLEOMYCIN; BUSULFAN; EPIPODOPHYLLOTOXIN; GLUCOCORTICOID; METHOTREXATE; PLATINUM; VINCA ALKALOID;

ADULT; ADVERSE OUTCOME; AGED; ARTICLE; BREAST CANCER; CANCER SURVIVOR; CARDIOMYOPATHY; CATARACT; CHILDHOOD CANCER; CHRONIC DISEASE; CLINICAL ASSESSMENT; COGNITIVE DEFECT; COHORT ANALYSIS; DRUG EXPOSURE; ENDOCRINE DISEASE; FEMALE; FOLLOW UP; GONAD DYSFUNCTION; HEALTH STATUS; HEARING IMPAIRMENT; HEMATOLOGIC DISEASE; HUMAN; HYPOPHYSIS DISEASE; KIDNEY DYSFUNCTION; LIVER DYSFUNCTION; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; OSTEOPOROSIS; PATIENT MONITORING; PERIPHERAL NEUROPATHY; PREMATURE OVARIAN FAILURE; PREVALENCE; PRIORITY JOURNAL; RADIATION EXPOSURE; RISK ASSESSMENT; SYSTOLIC DYSFUNCTION; THYROID DISEASE; VALVULAR HEART DISEASE;

EID: 84878854824     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2013.7498     Document Type: Erratum

References (24)

1. Geenen MM, Cardous-Ubbink MC, Kremer LC, et al. Medical assessment of adverse health outcomes in long-term survivors of childhood cancer. JAMA. 2007;297(24):2705-2715. (Pubitemid 47001096)
2. Oeffinger KC, Mertens AC, Sklar CA, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med. 2006;355(15):1572-1582. (Pubitemid 44547808)
3. Sun CL, Francisco L, Kawashima T, et al. Prevalence and predictors of chronic health conditions after hematopoietic cell transplantation. Blood. 2010;116(17):3129-3139.
4. Dowling E, Yabroff KR, Mariotto A, McNeel T, Zeruto C, Buckman D. Burden of illness in adult survivors of childhood cancers. Cancer. 2010;116(15):3712- 3721.
5. Rebholz CE, Reulen RC, Toogood AA, et al. Health care use of long-term survivors of childhood cancer. J Clin Oncol. 2011;29(31):4181-4188.
6. Hudson MM, Ness KK, Nolan VG, et al. Prospective medical assessment of adults surviving childhood cancer. Pediatr Blood Cancer. 2011;56(5):825-836.
7. Ojha RP, Oancea SC, Ness KK, et al. Assessment of potential bias from non-participation in a dynamic clinical cohort of long-term childhood cancer survivors. Pediatr Blood Cancer. 2013;60(5):856-864.
8. Children's Oncology Group. Long-Term Fol-low- Up Guidelines for Survivors of Childhood, Adolescent, and Young Adult Cancers, Version 3.0. http://www.survivorshipguidelines.org. Accessed January 28, 2013.
9. Cancer Therapy Evaluation Program (CTEP). National Cancer Institute website. http://dctd.cancer.gov/ProgramPages/CTEP/. Accessed May 6, 2013.
10. Rückinger S, von Kries R, Toschke AM. An illustration of and programs estimating attributable fractions in large scale surveys considering multiple risk factors. BMC Med Res Methodol. 2009;9:7.
11. Allison PD. Survival Analysis Using the SAS System: A Practical Guide. Cary, NC: SAS Institute Inc; 1995.
12. Staba Hogan MJ, Ma X, Kadan-Lottick NS. New health conditions identified at a regional childhood cancer survivor clinic visit. Pediatr Blood Cancer. 2013;60(4):682-687.
13. Landier W, Armenian SH, Lee J, et al. Yield of screening for long-term complications using the Children's Oncology Group long-term follow-up guidelines. J Clin Oncol. 2012;30(35):4401-4408.
14. Wasilewski-Masker K, Mertens AC, Patterson B, Meacham LR. Severity of health conditions identified in a pediatric cancer survivor program. Pediatr Blood Cancer. 2010;54(7):976-982.
15. Hudson MM, Neglia JP, Woods WG, et al. Lessons from the past: opportunities to improve childhood cancer survivor care through outcomes investigations of historical therapeutic approaches for pediatric hematological malignancies. Pediatr Blood Cancer. 2012;58(3):334-343.
16. Green DM, Kun LE, Matthay KK, et al. Relevance of historical therapeutic approaches to the contemporary treatment of pediatric solid tumors [published online February 15, 2013]. Pediatr Blood Cancer. doi:10.1002/pbc.24487.
17. Asbell PA, Dualan I, Mindel J, Brocks D, Ahmad M, Epstein S. Age-related cataract. Lancet. 2005;365(9459):599-609. (Pubitemid 40247918)
18. Frisina RD. Age-related hearing loss: ear and brain mechanisms. Ann N Y Acad Sci. 2009;1170:708-717.
19. Glisky EL. Changes in cognitive function and human aging. In: Riddle DR, ed. Brain Aging: Models, Methods, and Mechanisms. Boca Raton, FL: CRC Press; 2007.
20. Marin-Garcia J, Goldentha MJ, Moe GW. Cardiomyopathy and heart failure in aging. In: Marin- Garcia J, ed. Aging and the Heart. Secaucus, NJ: Springer US; 2008:209-238.
21. Parry C, Kent EE, Mariotto AB, Alfano CM, Rowland JH. Cancer survivors: a booming population. Cancer Epidemiol Biomarkers Prev. 2011;20(10):1996-2005.
22. Armstrong GT, Reddick WE, Peterson RC, et al. Evaluation of memory impairment in aging adult survivors of childhood acute lymphoblastic leukemia treated with cranial radiotherapy [published online April 12, 2013]. J Natl Cancer Inst. doi:10.1093/jnci/djt089.
23. de Haas EC, Oosting SF, Lefrandt JD, Wolffenbuttel BH, Sleijfer DT, Gietema JA. The metabolic syndrome in cancer survivors. Lancet Oncol. 2010;11(2):193-203.
24. Mertens AC, Liu Q, Neglia JP, et al. Cause-specific late mortality among 5-year survivors of childhood cancer. J Natl Cancer Inst. 2008;100(19):1368- 1379.